Search research articles
Contact Us
Filters
Showing results (171-180 of 196) with videos related to
Page
of 20
Sort By:
Annals of the Rheumatic Diseases
|
April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
Josef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Annals of the Rheumatic Diseases
|
November 14, 2022
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
April 8, 2026
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Faidra Laskou, Victoria Konzett, Josef S Smolen, et al.
Rheumatology (Oxford, England)
|
April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Annals of the Rheumatic Diseases
|
June 2, 2026
Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force
Victoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Annals of the Rheumatic Diseases
|
April 17, 2026
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Victoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Rheumatology (Oxford, England)
|
May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Annals of the Rheumatic Diseases
|
August 14, 2020
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training
Francisca Sivera, Alessia Alunno, Aurélie Najm, et al.
Rheumatology (Oxford, England)
|
December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
RMD Open
|
November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe
Søren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 196) with videos related to
Sort By:
Page
of 20
Annals of the Rheumatic Diseases
|
April 3, 2016
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
Josef S Smolen, Sabine Collaud Basset, Maarten Boers, et al.
Annals of the Rheumatic Diseases
|
November 14, 2022
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
April 8, 2026
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Faidra Laskou, Victoria Konzett, Josef S Smolen, et al.
Rheumatology (Oxford, England)
|
April 22, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Annals of the Rheumatic Diseases
|
June 2, 2026
Evaluating machine learning tools to assist title and abstract screening in systematic literature reviews: a report based on the EULAR RA Management Recommendations Task Force
Victoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Annals of the Rheumatic Diseases
|
April 17, 2026
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2025 update of the EULAR recommendations for the management of rheumatoid arthritis
Victoria Konzett, Faidra Laskou, Josef S Smolen, et al.
Rheumatology (Oxford, England)
|
May 27, 2017
The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
Annals of the Rheumatic Diseases
|
August 14, 2020
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training
Francisca Sivera, Alessia Alunno, Aurélie Najm, et al.
Rheumatology (Oxford, England)
|
December 8, 2017
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, et al.
RMD Open
|
November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe
Søren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Page
of 20